The Korean Journal of Nuclear Medicine (대한핵의학회지)
- Volume 20 Issue 2
- /
- Pages.61-71
- /
- 1986
- /
- 1225-6714(pISSN)
Therapeutic Feasibility Study and Clinical Trial of Intrahepatic $I^{-131}-Lipiodol$ on Patients with Hepatocellular Carcinoma
$Lipiodol-I^{-131}$ 의 경간동맥 주입에 의한 간암치료의 가능성에 관한 연구
- Yoo, Hyung-Sik (Department of Radiology, Yonsei University, College of Medicine) ;
- Suh, Jung-Ho (Department of Radiology, Yonsei University, College of Medicine) ;
- Lee, Jong-Tae (Department of Radiology, Yonsei University, College of Medicine) ;
-
Kim, Dong-Ik
(Department of Radiology, Yonsei University, College of Medicine) ;
- Park, Chang-Yun (Department of Radiology, Yonsei University, College of Medicine) ;
- Kim, Byung-Soo (Yonsei Canter Center) ;
- Park, Chan-H. (Division of Nuclear Medicine, Thomas Jefferson University Hospital) ;
- Thakur, M. (Division of Nuclear Medicine, Thomas Jefferson University Hospital)
- 유형식 (연세대학교 의과대학 방사선과학교실) ;
- 서정호 (연세대학교 의과대학 방사선과학교실) ;
- 이종태 (연세대학교 의과대학 방사선과학교실) ;
-
김동익
(연세대학교 의과대학 방사선과학교실) ;
- 박창윤 (연세대학교 의과대학 방사선과학교실) ;
- 김병수 (연세암센타) ;
- 박찬희 (미국 Thomas Jefferson 의과대학 핵의학교실) ;
- Published : 1986.12.31
Abstract
An iodized oil such as Ethiodol or Lipiodol was selectively retained in the tumor vessels of the large hepatomas as well as in the small daughter hepatomas for long periods following the intra-arterial hepatic injection of such contrast material. The specific aim of the study is to deliver a high internal radiation dose to hepatocellular carcinoma (HCC) in an attempt to control the disease. We were able to replace a small fraction of the stable iodine (I-127) of the 37% iodine in Lipiodol by the
Keywords